AUROBIN OINTMENT 20G

$24.70
No tax

AUROBIN OINTMENT 20G

Quantity

 

Security policy (edit with Customer reassurance module)

 

Delivery policy (edit with Customer reassurance module)

 

Return policy (edit with Customer reassurance module)

Mechanism of action

The combined preparation for topical administration. The action of the drug is due to the properties of the components that comprise it: prednisolone capronate - non-halogenated GCS, Lidocaine hydrochloride - a local anesthetic, d-panthenol - a means of stimulating the regeneration of the epithelium, triclosan - an antimicrobial agent with a wide spectrum of action.
The drug has anti-inflammatory, anti-allergic, anti-exudative, local analgesic, antiseptic and stimulating regeneration effect.

Data on the pharmacokinetics of the drug Aurobin not provided.

Indications and usage

Processes involving inflammation of the anorectal region:
- an itch of an anus;
- Perianal eczema;
- psoriasis of the perianal region;
- Perianal dermatitis;
- hemorrhoids;
- fistula and anal fissures;
- anopapillite.

Ointment is applied with a thin layer on the affected surface 2-4 times / day.
At internal hemorrhoids a small amount of ointment 2-4 times / day injected into the rectum.
When the severity of symptoms decreases, ointment is used less frequently (1-2 times / day).

Adverse reactions

Dermatologic: rarely - telangiectasia, erythema, hypertrichosis, superficial atrophy of the skin (with prolonged use of the drug).
Other: With prolonged use of the drug and / or its application to the extensive surface of the skin, systemic side effects characteristic of glucocorticoids are possible.
With the introduction of an excess amount of ointment into the rectum, moderate bradycardia is possible.

Contraindications

- specific lesions of the anorectal region (including viral, bacterial and fungal infections);
- tumors and precancerous skin diseases;
- hypersensitivity to the drug.

Pregnancy and breastfeeding

With extreme caution should apply Aurobin in the first trimester of pregnancy.
Data on the safety of Aurobin during lactation (breastfeeding) are not available.

Special notes

In the case of applying the ointment on a vast surface for a long time, it is necessary to consider the possibility of resorption of the active substances of the drug into the systemic circulation.

Overdosage

Data overdose Aurobin no.

Drug Interactions

With simultaneous use of Aurobin and lidocaine for systemic use, the effect of the latter is enhanced.

Storage conditions

The drug should be stored at a temperature not higher than 15 ° C. Shelf life - 2 years.

46 Items